More News

01 Jun 2007 Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
31 May 2007 IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
31 May 2007 Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer
31 May 2007 BioWa and Takeda announce licensing of BioWa's POTELLIGENT(R) technology for use in antibody research and development
31 May 2007 Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
31 May 2007 Mersana Therapeutics, Inc. Initiates Phase I Trial of Anti-Cancer Agent, XMT-1001, in Solid Tumors
31 May 2007 CeNeRx BioPharma, Inc. Announces Agreement With PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds
30 May 2007 Positive Final Data from HyCAMPTM Phase II Trial in Metastatic Colorectal Cancer
30 May 2007 Genzyme Corporation to Acquire Bioenvision, Inc.
30 May 2007 Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
30 May 2007 Angiotech initiates european trial examining the Vascular Wrapâ„¢ paclitaxel-eluting mesh for dialysis patients with end-stage renal disease
29 May 2007 Ranbaxy expands its presence in the us dermatology market
29 May 2007 Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study
29 May 2007 FUJIFILM, Cangen Biotechnologies Joint Development Agreement on Anti-cancer Drug Delivery System
26 May 2007 Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
26 May 2007 Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
25 May 2007 Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
25 May 2007 Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis
25 May 2007 Inovio Biomedical’s DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
24 May 2007 Abbott Initiates First Clinical Study of Everolimus Eluting Stent System for Patients with Peripheral Arterial Disease
24 May 2007 Organon and Philips team up to study drug effects at the molecular level
24 May 2007 ThromboGenics plans to absorb Belgian subsidiary Thromb-X
23 May 2007 Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine
23 May 2007 Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
23 May 2007 Phase 1b insulin clinical trial commenced

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top